State Street Corp Madrigal Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 887,752 shares of MDGL stock, worth $278 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

887,752

Previous 744,714 19.21%

Holding current value

$278 Million

Previous $209 Million 9.7%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$212.22 - $292.96 $30.4 Million - $41.9 Million	143,038 Added 19.21%	887,752 $188 Million
Q2 2024 Aug 14, 2024	BUY	$193.33 - $291.99 $23.2 Million - $35 Million	119,776 Added 19.17%	744,714 $209 Million
Q1 2024 May 15, 2024	SELL	$171.37 - $283.23 $13 Million - $21.5 Million	-75,801 Reduced 10.82%	624,938 $167 Million
Q4 2023 Feb 14, 2024	BUY	$120.4 - $237.13 $7.04 Million - $13.9 Million	58,473 Added 9.1%	700,739 $162 Million
Q3 2023 Nov 14, 2023	BUY	$146.04 - $225.78 $14.4 Million - $22.2 Million	98,507 Added 18.12%	642,266 $93.8 Million
Q2 2023 Aug 14, 2023	BUY	$203.88 - $312.0 $4.88 Million - $7.47 Million	23,945 Added 4.61%	543,759 $126 Million
Q1 2023 May 15, 2023	SELL	$231.06 - $307.08 $171 Million - $228 Million	-741,179 Reduced 58.78%	519,814 $126 Million
Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $17.2 Million - $87.3 Million	294,352 Added 30.45%	1,260,993 $366 Million
Q3 2022 Nov 15, 2022	BUY	$60.57 - $79.51 $8.56 Million - $11.2 Million	141,334 Added 17.13%	966,641 $62.8 Million
Q2 2022 Aug 15, 2022	BUY	$58.04 - $100.2 $3.45 Million - $5.95 Million	59,428 Added 7.76%	825,307 $59.1 Million
Q1 2022 May 16, 2022	BUY	$55.89 - $101.89 $9.34 Million - $17 Million	167,131 Added 27.91%	765,879 $75.1 Million
Q4 2021 Feb 14, 2022	SELL	$72.34 - $95.09 $11.6 Million - $15.2 Million	-159,867 Reduced 21.07%	598,748 $50.7 Million
Q3 2021 Nov 15, 2021	BUY	$78.35 - $105.02 $10.7 Million - $14.3 Million	136,153 Added 21.87%	758,615 $60.5 Million
Q2 2021 Aug 16, 2021	BUY	$97.2 - $137.59 $3.57 Million - $5.05 Million	36,712 Added 6.27%	622,462 $60.6 Million
Q1 2021 May 17, 2021	SELL	$108.54 - $125.2 $6.26 Million - $7.22 Million	-57,665 Reduced 8.96%	585,750 $68.5 Million
Q4 2020 Feb 16, 2021	BUY	$110.06 - $133.7 $23.4 Million - $28.4 Million	212,171 Added 49.2%	643,415 $71.5 Million
Q3 2020 Nov 10, 2020	SELL	$99.78 - $124.21 $17.4 Million - $21.6 Million	-173,991 Reduced 28.75%	431,244 $51.2 Million
Q2 2020 Aug 14, 2020	BUY	$60.13 - $125.71 $7.72 Million - $16.1 Million	128,455 Added 26.94%	605,235 $68.5 Million
Q1 2020 May 11, 2020	BUY	$66.76 - $93.49 $31.8 Million - $44.6 Million	476,780 New	476,780 $31.8 Million

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.36B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Madrigal Pharmaceuticals, Inc. Transaction History